By: Erica Dimitropoulos Co-Copy Editor [Content- Focused] - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…
By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…
By: Steve Soman, Co-Editor-in-Chief - Varicella Zoster Immune Globulin (Varizig®) was approved by the FDA on December 21st of 2012.…